Hey Ed, you may want to screen for biotechs
which are breaking out of bases...Here is
a post I put on MS usenet groups today, need
to refine lists obviously to catch the ones
that are truly breaking out of course...but
there should be a few opportunities. I would
not be especially agressive, awfully late
in the bull market, watch your step. But as
you know, biotech has been really dead for
me, so I thought I'd bring it to your attention
since things are finally perking up a bit.
Just today...with DOW down 0.2% today at 11,000,
the Nasdaq was up 1.6%, and the S&P up 0.6%.
+3.92% Biotech (Sales under $10MM)
+2.01% Genomic Database
+1.28% Large Pharmaceuticals
+1.23% Biotech (Sales more than $10MM)
+1.22% Generic Drugs
+1.07% Skin Care
+0.95% Tissue Engineering
+0.60% Drug Delivery
In that first group, these were the top gainers--
Ribozyme Pharmaceuticals RZYM 36.3%
La Jolla Pharmaceutical LJPC 32.5%
Zonagen ZONA 19.8%
Cambridge NeuroScience CNSI 17.6%
AMBI AMBI 14.0%
VIMRX Pharmaceuticals VMRX 12.5%
Immune Response IMNR 12.1%
Imclone Systems IMCL 9.3%
XOMA XOMA 7.5%
Immunomedics IMMU 7.3%
Cadus Pharmaceutical KDUS 7.1%
Alexion Pharmaceuticals ALXN 7.1%
From my various watch lists,
"Jubak list"--CORR strongest, up 6.4% today,
has run from $12 to $14 in past five days.
In my "McCamant" list, I see ImClone was up
9% today--and has run from just under $18
to around $22 since the close last week.
Sugen is in my aacr/asco watch list, it was
up 4.4% today, and has run from $19 to $21
in the past few days.
In my micro list, BTRN--Biotransplant has run
from $3 to near $4 in the last couple days.
In a genomics watch list I have Gene Logic,
Human Genome, and Incyte were all up today...
about 8%,7%, and 4% respectively. All three
look good to run some more.
On my list--the biotechs I own, only CNSI looked
strong today, worth a mention I think.
Frankly, I'm a little overwhelmed--I don't have
good charting capability--just yahoo, so don't
know whether I will try and jump on something
for a ride, or just sit tight with my holds.
Recently I rode ONXX for a few grand, then they
put out a boring quarterly, so I bailed, it does
seem to have topped out anyway.
Good luck to all, will let you know if I find
something good for tommorrow--I have the morning
off, so I may get to do a trade. Will check the
biotech guru's lists and see if anything is
doing well there too...here is link to that,
Message 9499355
I see they are still shorting ICOS, I am against
that on principal, but I respect their opinion on
the valuation--so that is one not to buy. |
